Updates matching "Access to Health Care"

A new national poll reveals that patients are counting on lawmakers to solve the medical debt crisis. U.S. adults say it is past time for federal and state policymakers to act.

A coalition of the country’s leading public health advocacy organizations filed a friend-of-the-court brief in Texas v. Mayorkas in the United States District Court for the Southern District of Texas to urge the court to uphold the Biden administration’s 2022 “public charge” policy. Amici include American Cancer Society; American Cancer Society Cancer Action Network (ACS CAN); American Lung Association; CancerCare; Epilepsy Foundation; Hemophilia Federation of America; Leukemia & Lymphoma Society; Muscular Dystrophy Association; National Multiple Sclerosis Society; National Patient Advocate Foundation; and Susan G. Komen.

The nation’s drug shortage crisis continues to affect cancer patients and survivors with 1 in every 10 (10%) reporting impacts to care, a majority of whom have had difficulties finding substitute medications (68%) and cited treatment delays (45%). The data is part of a new survey by the American Cancer Society Cancer Action Network (ACS CAN).

WASHINGTON, D.C. – October 12, 2023 –Today, the American Cancer Society and the American Cancer Society Cancer Action Network (ACS CAN) joined with other leading national patient groups in filing an amicus curiae (or friend-of-the-court) brief urging the Supreme Court to take up the case of

Today, the American Cancer Society Cancer Action Network (ACS CAN) was overjoyed to see the legislature pass oral chemotherapy fairness legislation. ACS CAN looks forward to seeing the Governor sign this critical legislation into law soon and celebrating our volunteers’ hard work to get this legislation over the finish line.

Earlier this week, 22 cancer patient and caregiver advocacy groups, including the American Cancer Society Cancer Action Network (ACS CAN), sent a letter to the Centers for Medicare & Medicaid Services (CMS) offering recommendations on how the agency should consider pharmaceutical therapeutic alternatives to selected oncology drugs for 2026 Medicare plans as they head into the negotiation process laid out in the Inflation Reduction Act (IRA).

The American Cancer Society Cancer Action Network (ACS CAN) was thrilled to see the Senate Health Policy Committee pass oral chemotherapy fairness legislation unanimously today.

FORT MYERS, FL -- The most rewarding part of our roles as oncology providers is the opportunity to extend and enrich lives. It enables people to witness cherished milestones such as a child’s wedding or the birth of a grandchild. The oncology world is witnessing a transformative phase with